
AstraZeneca Pharma India Share Price
₹7,872.40 +246.8 (3.24%)
11 Mar, 2025 12:27
Start SIP in
ASTRAZEN
Performance
- Low
- ₹7,512
- High
- ₹7,990
- 52 Week Low
- ₹4,785
- 52 Week High
- ₹8,139
- Open Price₹7,590
- Previous Close₹7,626
- Volume106,007
Investment Returns
- Over 1 Month + 4.82%
- Over 3 Month + 19.34%
- Over 6 Month + 14.97%
- Over 1 Year + 45.87%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 203
- PEG Ratio
- -6.7
- Market Cap Cr
- 19,681
- P/B Ratio
- 29
- Average True Range
- 277.18
- EPS
- 67.05
- Dividend Yield
- 0.3
- MACD Signal
- 3.04
- RSI
- 66.03
- MFI
- 71.59
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹7,872.40
+
246.8
(3.24%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹7,202.88
- 50 Day
- ₹7,121.36
- 100 Day
- ₹7,024.78
- 200 Day
- ₹6,731.95
Resistance and Support
7613.53
- R3 7,927.07
- R2 7,818.53
- R1 7,722.07
- S1 7,517.07
- S2 7,408.53
- S3 7,312.07
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹7,872 As on 11 March, 2025 | 12:13
The Market Cap of AstraZeneca Pharma India is ₹19681 Cr As on 11 March, 2025 | 12:13
The P/E ratio of AstraZeneca Pharma India is 203 As on 11 March, 2025 | 12:13
The PB ratio of AstraZeneca Pharma India is 29 As on 11 March, 2025 | 12:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.